NDC 50090-7565-01 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7565
- Requested NDC
- 50090-7565-01
- Package NDCs from labels
- 50090-7565-0, 50090-7565-1, 50090-7565-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-06-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - A-S Medication Solutions | A-S Medication Solutions | 2025-06-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7565-0 | Levothyroxine Sodium | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 50090-7565-1 | Levothyroxine Sodium | 90 in 1 BOTTLE | TABLET | 90 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7565-0 | EA - Each | 50090-7565 | f8985b7e-0db9-4f27-a578-d03114d20ddc | 1 | 2025-07-08 |
| 50090-7565-1 | EA - Each | 50090-7565 | 9ae58399-1062-4606-bc3b-72a38fe5fd7c | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 4a2c8e57-d52d-409f-83d8-731b721bf613 | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 4caf9040-5507-45a4-8f42-231aa925ab8d | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 4f97d398-2118-0874-e063-6394a90a4ad1 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 8MDF5V39QO |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | f347d92a-7726-4165-bc3c-f5b37ec86f9f | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate 10 gr. (650 mg) | SODIUM BICARBONATE | Gendose Pharmaceuticals, LLC | 0a0cc46d-372e-4175-932a-065e82d8d353 | 2026-04-13 | Warnings | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | f8c14539-8ed1-406a-9b58-8ba3a7ce7ee3 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 0210a600-747e-433a-8ba9-11692ecfb54a | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | ef7bc627-d37b-470e-b8f7-3c472c930d05 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | d0beda93-9454-4846-b5c6-2a9113fb1765 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 892255 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 0b9d21d8-9b49-4fd2-b516-b25bc6a6b671 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | caf7825d-f434-472f-94f3-217a41255562 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | 966249 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 55cebc88-0514-4940-b974-ec7f0467d10e | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | c7d5b71b-e983-4b1a-bfc2-d2343cf8668c | 2026-04-06 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea9f4498-0d43-4043-8dd1-f22537841c21 | 2026-04-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 8664c7ce-707b-4c6c-9ce4-7160b5f877f8 | 2026-04-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 0235176b-ec39-44c4-a9e1-e0729a7989fa | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966253 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.